Magnetic Resonance - Technology Information Portal Welcome to MRI Technology••
Info
  Sheets


Out-
      side
 

In 2020 your scanner will probably work with a field strength of :
lower 
1T 
1.5T 
2T 
3T 
7T 
higher 




 
MRI News Service:
'AMAG Pharmaceuticals, Inc'
SEARCH NEWS FOR   
 
Result: Searchterm 'AMAG Pharmaceuticals, Inc' found in 22 news
Result Pages
More Results: Database  (10)  
News Refinements:  Contrast Agents  Devices  Financial  
Combidex Technology Sale Opens Door to a Revolution in Diagnostic Cancer Imaging
''''The exclusive technology and development rights to Combidex® (ferumoxtran-10), a contrast agent showing great potential in the field of diagnostic imaging, have been sold by the U.S. pharmaceutical company AMAG Pharmaceuticals, Inc. to a Dutch University ...'
Monday, 8 April 2013   by www.sfgate.com
Rienso® (Ferumoxytol) Launched in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease Launch Triggers $15 Million Milestone Payment to AMAG
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that Takeda Pharmaceutical Company Limited, AMAG's partner in Europe, has launched ferumoxytol in its first European Union (EU) market, under the brand name Rienso®. The launch follows the ...'
Monday, 5 November 2012   by ir.amagpharma.com
Rienso® (Ferumoxytol) Receives European Marketing Authorization for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the European Commission has granted marketing authorization for ferumoxytol, an intravenous (IV) iron therapy to treat iron deficiency anemia (IDA) in adult patients with chronic kidney ...'
Friday, 22 June 2012   by ir.amagpharma.com
AMAG Pharmaceuticals Announces a Positive CHMP Opinion for the Approval of Ferumoxytol in Europe for the Treatment of Iron Deficiency Anemia in Adult Patients with Chronic Kidney Disease
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion for the approval of ferumoxytol, an intravenous (IV) iron ...'
Friday, 20 April 2012   by ir.amagpharma.com
AMAG Pharmaceuticals Announces Update to Feraheme(R) Label
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that the company has updated the product label for Feraheme(R) (ferumoxytol) Injection for Intravenous (IV) use. This update is based on the U.S. Food and Drug Administration's approval of the ...'
Tuesday, 21 June 2011   by ir.amagpharma.com
AMAG Announces Fourth Quarter and Year End 2010 Financial Results
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the fourth ...'
Friday, 25 February 2011   by ir.amagpharma.com
AMAG Pharmaceuticals Announces Financial Results for the Third Quarter Ended September 30, 2010 and a Restructuring Plan to Reduce Operating Expenses
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia, today reported unaudited consolidated financial results for the third ...'
Thursday, 28 October 2010   by ir.amagpharma.com
AMAG Pharmaceuticals Announces Financial Results for the Second Quarter and Six Months Ended June 30, 2010
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG), a biopharmaceutical company focused on the development and commercialization of a therapeutic iron compound to treat iron deficiency anemia and novel imaging agents to aid in the diagnosis of cancer and ...'
Wednesday, 28 July 2010   by www.snl.com
AMAG Pharmaceuticals and Takeda Announce Acceptance of Submission of Feraheme® Marketing Authorization Application to the European Medicines Agency
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) and Takeda Pharmaceutical Company Limited (TSE: 4502) today provided a regulatory and clinical update for Feraheme® (ferumoxytol) Injection for intravenous (IV) use. On June 1, 2010, AMAG submitted a ...'
Tuesday, 29 June 2010   by www.snl.com
AMAG Pharmaceuticals, Inc. to Present at Upcoming Investor Conferences
''''AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present at the following investor conferences during the month of June: June 9, at 8:00 a.m. ET – 9th Annual Needham Healthcare Conference in New York City; June 10, at ...'
Friday, 4 June 2010   by www.snl.com
News Refinements:  Contrast Agents  Devices  Financial  
Radiology News Open this link in a new window Ultrasound Imaging News Open this link in a new window
Result Pages
Age is not a particularly interesting subject. Anyone can get old. All you have to do is live long enough.
- Groucho Marx
 
Share This Page
FacebookTwitterLinkedIn

MR-TIP    
Community   
User
Pass
Forgot your UserID/Password ?  



Look
      Ups





MR-TIP.com uses cookies! By browsing MR-TIP.com, you agree to our use of cookies.

Magnetic Resonance - Technology Information Portal
Member of SoftWays' Medical Imaging Group - MR-TIP • Radiology-TIP • US-TIP • 
Copyright © 2003 - 2018 SoftWays. All rights reserved. [ 17 February 2019]
Terms of Use | Privacy Policy | Advertising
 [last update: 2018-03-08 05:11:00]